Other

Regulatory Asset

Exelon Regulatory Asset decreased by 0.7% to $10.57B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Regulatory Asset shows relatively stable performance with a 3.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024

How to read this metric

An increase suggests significant capital investment or deferred costs awaiting rate recovery, which may impact future cash flow timing.

Detailed definition

Represents costs incurred by the utility that are expected to be recovered from customers through future rate adjustment...

Peer comparison

Standard for regulated utilities; high levels are typical for companies with large infrastructure investment programs.

Metric ID: other_regulatory_assets

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$9.68B$10.91B$10.65B$10.57B
QoQ Change+12.8%-2.4%-0.7%
YoY Change+12.8%-2.4%-0.7%
Range$9.68B$10.91B
Avg YoY Growth+3.2%
Median YoY Growth-0.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is Exelon's regulatory asset?
Exelon (EXC) reported regulatory asset of $10.57B in Q4 2025.
What is the long-term trend for Exelon's regulatory asset?
Over 3 years (2022 to 2025), Exelon's regulatory asset has grown at a 3.0% compound annual growth rate (CAGR), from $9.68B to $10.57B.
What does regulatory asset mean?
Future costs that regulators have allowed the company to collect from customers later.